Intercept Pharmaceuticals Inc Ano de IPO
Qual é o Ano de IPO de Intercept Pharmaceuticals Inc?
O Ano de IPO de Intercept Pharmaceuticals Inc é 2012
Qual é a definição de Ano de IPO?
A oferta pública inicia (OPI)l é um tipo de oferta pública em que as ações de uma empresa geralmente são vendidas a investidores institucionais que, por sua vez, vendem para o público em geral, em uma bolsa de valores, pela primeira vez.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Ano de IPO de empresas na Setor Health Care em NASDAQ em comparação com Intercept Pharmaceuticals Inc
O que Intercept Pharmaceuticals Inc faz?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Empresas com ano de ipo semelhantes a Intercept Pharmaceuticals Inc
- American Century ETF Trust tem Ano de IPO de 2011
- Sino Harbour tem Ano de IPO de 2011
- Horizons Gold Prod Equty Cvrd C tem Ano de IPO de 2011
- HFX tem Ano de IPO de 2011
- Dark Horse Resources tem Ano de IPO de 2011
- Om Metals Infraprojects tem Ano de IPO de 2011
- Intercept Pharmaceuticals Inc tem Ano de IPO de 2012
- Evertec Inc tem Ano de IPO de 2013
- Virtus Health tem Ano de IPO de 2013
- Antero Resources Corp tem Ano de IPO de 2013
- Murphy USA Inc tem Ano de IPO de 2013
- Kodal Minerals Plc tem Ano de IPO de 2013
- Agios Pharmaceuticals Inc tem Ano de IPO de 2013